BOSNIA AND HERZEGOVINA

KISS THE FUTURE – The Critically Acclaimed Documentary About a Creative Community Amid the Siege of Sarajevo, the Resilience of Its People Through Art and Music and the Tale of a Post-war Concert by U2 – to Receive a Theatrical Run Exclusively at AMC

Retrieved on: 
Wednesday, January 31, 2024
Arts, Museums, Entertainment, Other Entertainment, Film & Motion Pictures, Celebrity, Music, Events, Concerts, WME, AMC, Life, City, FUTURE, Ben Affleck, Tribeca Festival, AMC Theatres, Edge, United, Equity, Sale, U2, KISS, Film industry

“Even in the darkest times, the people of Sarajevo were able to find purpose through playing music, making art and helping others.

Key Points: 
  • “Even in the darkest times, the people of Sarajevo were able to find purpose through playing music, making art and helping others.
  • Tickets to this special event, presented in Dolby Cinema, are on sale now at amctheatres.com or on the AMC Theatres mobile app.
  • KISS THE FUTURE was financed and produced by FIFTH SEASON and is a FIFTH SEASON, Artists Equity, and an In Cahoots Production.
  • Guests can find showtimes and purchase tickets at amctheatres.com or on the AMC Theatres mobile app.

Bosnia and Herzegovina in 2040: The Future Demographic Report - ResearchAndMarkets.com

Retrieved on: 
Friday, January 5, 2024
Lifestyle, Consumer, Travel, Habit, Health, Education, Future, Use, Clothing, Longevity, Investment, Tourism, Pressure, Communication, Environment

The "Bosnia and Herzegovina in 2040: The Future Demographic" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Bosnia and Herzegovina in 2040: The Future Demographic" report has been added to ResearchAndMarkets.com's offering.
  • The Bosnia and Herzegovina in 2040: The Future Demographic report analyses factors influencing national consumer expenditure.
  • Use this report to understand the factors influencing a nation's lifestyle choices.
  • Continuing depopulation in Bosnia and Herzegovina in 2021-2040 will be driven mainly by natural decrease, though negative net migration rates after 2023 will also influence this trend.

Horus Pharma Is Strengthening Its International Expansion in Support of Its Growth

Retrieved on: 
Tuesday, December 5, 2023
Health, Other Health, Other Science, Research, Science, Optical, Biotechnology, Corporation, Ophthalmology, Retina, SME, Marketing, Moritz Moszkowski, Growth, Pharma, Glaucoma, Economic development, Pharmaceutical industry, Fine chemical

“We have made international expansion a key part of our growth since 2015.

Key Points: 
  • “We have made international expansion a key part of our growth since 2015.
  • Our international network constitutes a unique platform for marketing products and supporting the development of new treatments specific to local needs,” said Claude Claret, co-founder and CEO of Horus Pharma.
  • Horus Pharma’s portfolio features 60 innovative ophthalmology products and solutions, including cornea, eyelid, glaucoma and retina treatments, along with food supplements.
  • Horus Pharma has been selected to join the ETIncelles programme, which features 100 small and medium-sized enterprises (SMEs) with strong economic development potential.

Saudi Fund for Development Breaks Ground for the Library of the University of Sarajevo

Retrieved on: 
Tuesday, August 1, 2023
Research, Construction & Property, Philanthropy, Fund Raising, University, Foundation, Other Construction & Property, Science, Education, Male, Communication, SDG, Sustainable Development Goal 4, SFD, Multimedia, International University of Sarajevo, Student, Faculty, Saudi Fund for Development, Knowledge, Kingdom, Female, Tourism, Drug

Ahmed Al-Khateeb, laid the foundation stone, to kick off the construction and equipping of the new library in the University of Sarajevo, funded through a generous $22 million grant provided by the Kingdom of Saudi Arabia, through SFD.

Key Points: 
  • Ahmed Al-Khateeb, laid the foundation stone, to kick off the construction and equipping of the new library in the University of Sarajevo, funded through a generous $22 million grant provided by the Kingdom of Saudi Arabia, through SFD.
  • Additionally, the library will play a key role in supporting the advancement of the university’s research and innovation capabilities.
  • We are confident that the new library will help meet the needs of both male and female students at the University of Sarajevo, and the surrounding community.
  • During the past three decades, SFD has helped to fund 11 projects and development programs in various regions of Bosnia and Herzegovina, through soft development loans worth a total of $185 million.

AM Best Affirms Credit Ratings of Bosna Reosiguranje d.d. Sarajevo

Retrieved on: 
Wednesday, July 5, 2023
Consulting, Professional Services, Insurance, Finance, Good, AM Best, ALL, Risk management, Credit, Capital adequacy ratio, GWP, AM, News

AM Best has affirmed the Financial Strength Rating of B+ (Good) and the Long-Term Issuer Credit Rating of “bbb-” (Good) of Bosna Reosiguranje d.d.

Key Points: 
  • AM Best has affirmed the Financial Strength Rating of B+ (Good) and the Long-Term Issuer Credit Rating of “bbb-” (Good) of Bosna Reosiguranje d.d.
  • The ratings reflect Bosna Re’s balance sheet strength, which AM Best assesses as very strong, as well as its adequate operating performance, limited business profile and appropriate enterprise risk management.
  • For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best’s Credit Ratings .
  • For information on the proper use of Best’s Credit Ratings, Best’s Performance Assessments, Best’s Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Best’s Ratings & Assessments .

Recent Report By Colliers Shows Analysis of CEE-15[i] countries has recorded increased enquiries for Small Business Units and Last Mile Logistics space

Retrieved on: 
Friday, July 1, 2022
LinkedIn, CEE, Internet, Capital market, Ownership, FMCG, EUR, SBU, City, LML, Leadership, Twitter, Collier, Marketing, Airline, Tourism

WARSAW, Poland, July 1, 2022 /PRNewswire/ -- The total stock of SBU (Small Business Units) / LML (Last Mile Logistics) space in the CEE-15 countries accounts for over 3 million sq m, but the development of this market is not evenly spread in this region. The largest amount of space is located in Poland (circa about 2 million sq m), reveals a new report by Colliers: „ExCEEding Borders Small Business Units & Last Mile Logistics Sector in CEE-15".

Key Points: 
  • The largest amount of space is located in Poland (circa about 2 million sq m), reveals a new report by Colliers: ExCEEding Borders Small Business Units & Last Mile Logistics Sector in CEE-15".
  • The increase in enquiries for SBU/LML space is also a consequence of this trend".
  • In that case, specific tenants in this sector lease smaller modules in big-box or smaller I&L schemes of lower standards.
  • Some projects are also built with a concept similar to modern SBU/LML schemes, but for private use.

AM Best Affirms Credit Ratings of Bosna Reosiguranje d.d. Sarajevo

Retrieved on: 
Thursday, June 23, 2022
Professional Services, Insurance, Finance, Credit, Industry, Good, Capital adequacy ratio, ALL, GWP, Insurance, AM, News, Risk management, AM Best, Reinsurance

AM Best has affirmed the Financial Strength Rating of B+ (Good) and the Long-Term Issuer Credit Rating of bbb- (Good) of Bosna Reosiguranje d.d.

Key Points: 
  • AM Best has affirmed the Financial Strength Rating of B+ (Good) and the Long-Term Issuer Credit Rating of bbb- (Good) of Bosna Reosiguranje d.d.
  • The ratings reflect Bosna Res balance sheet strength, which AM Best assesses as very strong, as well as its adequate operating performance, limited business profile and appropriate enterprise risk management.
  • For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Bests Credit Ratings .
  • For information on the proper use of Bests Credit Ratings, Bests Performance Assessments, Bests Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Bests Ratings & Assessments .

Endava Aims to Achieve Net Zero Emissions as an Organisation and Through Its Value Chain, Accelerating Its Journey to a Net Positive Impact

Retrieved on: 
Monday, February 14, 2022
Professional Services, Technology, Environment, Other Technology, Software, Consulting, Final good, Tree, Climate change, NYSE, TMT, DAVA, Risk, Carbon, SEC, Ideation, Phrase, Forward-looking statement, U.S. Securities and Exchange Commission, Solution, Letter, Security (finance), Private Securities Litigation Reform Act, Goal, Technology, Health care, Science, Silent Scope 3, Financial services, Mobility, Renewable energy, Risk management, Endava

We care about the world we live in and our focus is on achieving net zero emissions from our organisation and value chain, accelerating our journey to a net positive impact.

Key Points: 
  • We care about the world we live in and our focus is on achieving net zero emissions from our organisation and value chain, accelerating our journey to a net positive impact.
  • With this in mind we recently signed a commitment letter to Science Based Targets, which sees Endava joining the Race to Zero.
  • As a technology company, we are able to drive sustainability through digital acceleration and we are proud to help our clients build green solutions.
  • These forward-looking statements should not be relied upon as representing Endavas views as of any date subsequent to the date hereof.

Quoin Pharmaceuticals Signs Exclusive Distribution Agreement with ER-Kim for its Lead Asset, QRX003, for Netherton Syndrome

Retrieved on: 
Thursday, February 10, 2022
NASDAQ, Private Securities Litigation Reform Act, Mutation, GLOBE, Forward-looking statement, Growth, CEE, Allergy, Netherton syndrome, Lists of diseases, Company, Infection, Asthma, Dermatitis, Patient, Intermediary, SEC, Epidermolysis bullosa, Biotechnology, Peeling skin syndrome, CIS, SPINK5, Partnership, Dehydration, Risk, Pharmaceutical industry, Ichthyosis, Mediterranean Sea

ASHBURN, Va., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a specialty pharmaceutical company focused on rare and orphan diseases, today announced that its wholly-owned subsidiary, Quoin Pharmaceuticals, Inc., has entered into an exclusive Distribution Agreement with ER-Kim, a partner for biotech companies in Central and Eastern Europe (“CCE”), for QRX003, the Company’s investigational treatment for Netherton Syndrome, a rare and devastating genetic disease for which there is currently no available treatment or cure.

Key Points: 
  • Dr. Michael Myers, Chief Executive Officer of Quoin, commented, This is Quoins fifth distribution agreement for QRX003 since we went public four months ago.
  • The agreement with ER-Kim covers a number of important countries for rare and orphan diseases in Central and Eastern Europe.
  • Currently, there is no cure for Netherton Syndrome, nor are there any approved therapeutic treatments.
  • Quoin Pharmaceuticals Ltd. is an emerging specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases.

AFFIDEA SPEEDS UP DIGITISATION

Retrieved on: 
Thursday, February 10, 2022
Cloud, Senior, Culture, Google Images, Automation, Oracle Cloud, European Society of Radiology, Efficiency, Group, Patient, Safety, HR, GDPR, HCM, Teleradiology, Corporation, Environment, Oracle, HRIS, Digital, Medical imaging, Medicine, Management, Radiology

Other benefits of theOraclesystem implemented across Affidea include better management of continuous clinical education efforts by accessing the right professional audiences with specialised clinical training tailor made to their needs and knowledge exchange within peer-groups fostering transfer of best practices within internal medical professional networks.

Key Points: 
  • Other benefits of theOraclesystem implemented across Affidea include better management of continuous clinical education efforts by accessing the right professional audiences with specialised clinical training tailor made to their needs and knowledge exchange within peer-groups fostering transfer of best practices within internal medical professional networks.
  • OracleCloud HCM Cloud has been rolled out across all Affidea countries and it is the first step of Affidea ERP implementation across the Group.
  • The step-by-step concept made it easier for Affidea to accommodate to the solution and establish real ownership of the new globalHRIScloud system.
  • Affidea ( www.affidea.com ) is the largestEuropean provider of diagnostic imaging, outpatient and cancer care services, operating in 319centersacross15 countries in Europe.The Affidea Groupworks withover 9000 professionals serving more than over 10million patients every year.Thanks to its patients' safety track record, Affidea is the most awarded diagnostic imaging provider in Europe by the European Society of Radiology - over 50% of all centers assigned on the Eurosafe Star Wall belong to Affidea.